tiagabine has been researched along with arginine vasopressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Erhardt, A; Holsboer, F; Keck, ME; Mueller, MB; Ohl, F; Sillaber, I; Thoeringer, CK | 1 |
1 review(s) available for tiagabine and arginine vasopressin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for tiagabine and arginine vasopressin
| Article | Year |
|---|---|
Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Depression; GABA Agonists; GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; Gene Expression Regulation; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred C57BL; Nipecotic Acids; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; RNA, Messenger; Tiagabine | 2010 |